NCT03486249

Brief Summary

Weaning failure is associated with prolonged duration of mechanical ventilation that itself can worsen patient's prognosis. Therefore, identification of the causes and mechanisms leading to weaning failure is important in daily practice. While diaphragm dysfunction and pulmonary edema are two main causes of weaning failure, there are currently no data that quantify their respective contribution neither their potential co-existence. During weaning from mechanical ventilation, heart and lung interaction plays a major role. As a key factor, diaphragm function is therefore certainly involved in the occurrence of weaning-induced pulmonary edema. However, both phenomenons diaphragm dysfunction and weaning induced pulmonary edema have not been simultaneously investigated so far. This current project aims at exploring the relationship between diaphragm dysfunction and pulmonary in patients experiencing weaning failure. The objectives are 1) to quantify the respective contribution and co-existence of diaphragm dysfunction and weaning induced pulmonary edema and 2) to investigate the role of diaphragm function in the occurrence of weaning induced pulmonary edema.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 3, 2018

Completed
24 days until next milestone

Study Start

First participant enrolled

April 27, 2018

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2018

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 19, 2019

Completed
Last Updated

March 2, 2021

Status Verified

February 1, 2021

Enrollment Period

3 days

First QC Date

March 27, 2018

Last Update Submit

March 1, 2021

Conditions

Keywords

diaphragm dysfunctionventilator weaningpulmonary edema

Outcome Measures

Primary Outcomes (1)

  • Failure at the spontaneous breathing trial

    Weaning failure defined by the criteria of the International Conference on Weaning (Boles et al. ERJ 2007)

    During or at the end of the spontaneous breathing trial

Secondary Outcomes (3)

  • Rate of patients with diaphragm dysfunction

    At the end of the patient participation (Day 3)

  • Rate of patients with weaning induced pulmonary edema

    At the end of the patient participation (Day 3)

  • Rate of patients with diaphragm dysfunction and weaning induced pulmonary edema

    At the end of the patient participation (Day 3)

Study Arms (1)

Patient difficult to wean

EXPERIMENTAL

Repetition of medical examinations performed as part of the care. All patients will have a cardiac echo examination and diaphragm function assessment before the spontaneous breathing trial.

Other: Repetition of medical examinations performed as part of the care

Interventions

Cardiac echo, diaphragm ultrasound and phrenic nerves stimulation performed before the spontaneous breathing trial.

Patient difficult to wean

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients adult (age ≥ 18 years)
  • Intubation and invasive mechanical ventilation longer than 48 hours;
  • Failure to the first spontaneous breathing trial;
  • Presence of weaning readiness criteria
  • Oral informed consent
  • Patient with affiliation to the french healthcare system

You may not qualify if:

  • Pregnant women
  • Patient opposition
  • Contraindication to perform magnetic phrenic nerves stimulation technique (chest tube, cardiac pacemaker or implanted defibrillator, cervical implants, chest drains,...)
  • Impossibility to consider ventilator weaning (total ventilator dependence : preexisting neuromuscular disorders, cervical spine injury…)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Pitié-Salpétrière

Paris, 75013, France

Location

MeSH Terms

Conditions

Pulmonary Edema

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Martin DRES, MD, PhD

    Assistance Publique Hoptiaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: All patients will have a cardiac echo examination and diaphragm function assessment.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2018

First Posted

April 3, 2018

Study Start

April 27, 2018

Primary Completion

April 30, 2018

Study Completion

July 19, 2019

Last Updated

March 2, 2021

Record last verified: 2021-02

Locations